Loading live market data…

Johnson & Johnson

NYSE:JNJ

$248.34 USD

-$5.51 (-2.17%)

Volume
5.49M
Average Volume
8.14M
Market Capitalization
$597.81B
P/E Ratio
28.64
Dividend Yield
2.11%
Price Target
$265.00
Year High
$269.43
Year Low
$159.80
Day High
Day Low
Payout Ratio
$0.60
Current Ratio
$1.03
Source Headline
Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) is up 24.03% year to date and 65.92% over the past year, riding oncology strength and a raised full-year outlook.

247wallst.com - 2026-07-15 13:29:04

Wall Street Lunch: Dan Ives Teams Up With Yorkville Securities To Launch Merchant Bank

Tech analyst Dan Ives announced that he has teamed up with Yorkville Securities to form a new kind of merchant bank. Johnson & Johnson (JNJ) beat Q2 estimates and raised guidance, but EPS decline weighed on sentiment despite innovative medicine strength.

seekingalpha.com - 2026-07-15 12:32:00

Stock Market Is Giving A Pristine Entry Point Into This 64-Year Dividend King

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Pfizer (NYSE:PFE) both closed Q1 2026 with earnings beats, yet their post-report stories look nothing alike.

247wallst.com - 2026-07-15 12:27:23

J&J Leverages AI and Robots to Target $100 Billion in Annual Revenue

The launch of artificial intelligence-powered imaging and mapping capabilities for electrophysiology, early momentum for a drug releasing system for bladder cancer treatment, and progress toward a table-integrated robotic surgical system are among the latest innovations from pharmaceuticals and MedTech company Johnson & Johnson.

pymnts.com - 2026-07-15 12:09:07

Producer Inflation Cools in June

Pre-market futures are gathering steam following this morning's slew of economic data, which was quite encouraging overall. Wholesale inflation and another round of Q2 earnings results, along with a New York manufacturing index, has seen the blue-chip Dow up from +99 points to +140 at this hour.

zacks.com - 2026-07-15 11:55:34

J&J Q2 Earnings Beat on Darzalex, Tremfya Growth, 2026 Outlook Raised

JNJ tops Q2 earnings and sales estimates, driven by key drug growth, and raises its 2026 outlook despite a slight MedTech sales miss.

zacks.com - 2026-07-15 11:51:04

Johnson & Johnson Q2: Solid (If Not Spectacular) Performance Satisfies Wall Street

Johnson & Johnson delivered strong Q2 2026 results, with 6.6% annual revenue growth and robust performance across Pharma and MedTech divisions. JNJ maintains mid-to-high single digit revenue growth, a portfolio of 15+ "blockbuster" drugs, and a solid pipeline, supporting its blue-chip status. I am downgrading JNJ from Strong Buy to Buy due to valuation normalization and tempered forward share price expectations, despite continued operational strength.

seekingalpha.com - 2026-07-15 11:34:13

FTSE 100 Live: Miners drag on China slowdown, oil shrugs off new Iran strikes

FTSE 100 up 7 points at 10,537 Miners fall on weaker China GDP Barratt Redrow, ICG, B&M, NextEnergy Solar publish updates  2.50pm: US stocks open higher,...

proactiveinvestors.com - 2026-07-15 10:51:00

Johnson & Johnson beats Q2 estimates, raises full-year 2026 guidance

Johnson & Johnson (NYSE:JNJ) reported better-than-expected second quarter results and raised its full-year 2026 outlook, as strong pharmaceutical sales helped offset headwinds from products facing patent competition. The healthcare company posted adjusted earnings per share of $2.90 for the quarter, ahead of the Wall Street consensus estimate of $2.85.

proactiveinvestors.com - 2026-07-15 10:44:58

JNJ Struggles for Direction Despite Notable Q2 Beat

Johnson & Johnson (NYSE:JNJ) is up 0.5% at $255.03 this morning, attempting to pivot higher and shed its early pre-market losses.

schaeffersresearch.com - 2026-07-15 10:39:21

Johnson & Johnson (JNJ) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Johnson & Johnson (JNJ) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com - 2026-07-15 10:31:05

Johnson & Johnson Q2 Earnings Call Highlights

Johnson & Johnson NYSE: JNJ raised its full-year 2026 outlook after reporting second-quarter sales growth that management said was supported by strength in Innovative Medicine, new product launches and a broad portfolio that helped offset continued pressure from STELARA biosimilar competition.

marketbeat.com - 2026-07-15 10:05:37

Walmart vs Johnson & Johnson: Two Defensive Plays, Diverging Strategies and One Winner

Walmart (NYSE:WMT | WMT Price Prediction) and Johnson & Johnson (NYSE:JNJ) just delivered results that show two defensive giants pulling on very different levers.

247wallst.com - 2026-07-15 10:00:27

Chips Lead Nasdaq Futures Higher Amid Middle East Tensions

Stocks are moving higher the Nasdaq 100-Index (NDX) and Dow Jones Industrial Average (DJI) surging triple digits

schaeffersresearch.com - 2026-07-15 09:17:00

5 Things to Know Before the Stock Market Opens on Wednesday

Stock futures are pointing to a higher open as investors digest a flurry of earnings reports from major companies; oil prices are higher as the U.S. and Iran continue to trade strikes; PayPal shares are surging following a report that Stripe and Advent International have made a joint offer to buy the payments giant; ASML shares are gaining after the maker of chip manufacturing equipment reported strong results and lifted its sales forecast; and Morgan Stanley, Johnson & Johnson, Conagra and United are among the other big names reporting earnings today. Here's what you need to know today.

investopedia.com - 2026-07-15 09:01:00

Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates

Johnson & Johnson (JNJ) came out with quarterly earnings of $2.9 per share, beating the Zacks Consensus Estimate of $2.84 per share. This compares to earnings of $2.77 per share a year ago.

zacks.com - 2026-07-15 08:30:11

FTSE 100 Live: Miners drag on China slowdown, PayPal jumps on bid

FTSE 100 down 23 points to 10,506 Miners fall on weaker China GDP Barratt Redrow, ICG, B&M, NextEnergy Solar publish updates  12.13pm: European stocks in...

proactiveinvestors.com - 2026-07-15 08:13:00

Nasdaq continues rally as PayPal climbs on bid, BlackRock earnings impress

12:05pm: More impressive bank earnings Morgan Stanley (NYSE:MS) (Morgan Stanley (NYSE:MS)) reported record second quarter revenue and profit that topped...

proactiveinvestors.com - 2026-07-15 08:09:00

The State Tax Trap: Where the Same Retirement Portfolio Buys You Thousands More Every Year

Picture two retirees with identical $1.5 million portfolios throwing off $80,000 a year in taxable portfolio income. One lives in Naples, Florida. The other lives in San Diego. If that income is taxed as ordinary income and falls in California's 9.3% bracket, the California retiree could lose about $7,440 a year to state income tax... The State Tax Trap: Where the Same Retirement Portfolio Buys You Thousands More Every Year

247wallst.com - 2026-07-15 08:02:25

ASML, Intel, Johnson & Johnson, and More Stocks That Explain Today's Market

Stocks look set to build on their recent gains as investors try to make sense of another batch of quarterly earnings reports.

barrons.com - 2026-07-15 07:27:00

Johnson & Johnson Hikes Guidance, Stock Falls

The drugmaker posts earnings that narrowly beat expectations and raises its full-year outlook.

barrons.com - 2026-07-15 06:35:00

Johnson & Johnson Bumps Up Guidance as Sales Rise

The drug and medical-device maker raised its forecast for the year after recording higher sales in the second quarter.

wsj.com - 2026-07-15 06:33:00

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2026 of $1.34 per share on the company's common stock. The dividend is payable on September 8, 2026 to shareholders of record at the close of business on August 25, 2026. The ex-dividend date is August 25, 2026. About Johnson & Johnson At Johnson & Johnson, we believe health is everything. Our strength in healthcare inn.

businesswire.com - 2026-07-15 06:25:00

J&J quarterly earnings beat Wall Street estimates on strength of medicines unit

Johnson & Johnson beat Wall Street estimates for ​second-quarter sales and profit on Wednesday, as strong growth from immunology drug Tremfya ‌and cancer blockbuster Darzalex more than offset erosion from older products and a drop in sales for heart pumps it picked up in its 2022 acquisition of Abiomed.

reuters.com - 2026-07-15 06:23:09

Johnson & Johnson reports Q2 2026 results, raises 2026 outlook

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter 2026. “Johnson & Johnson delivered strong second-quarter results, demonstrating the power of our innovation, the depth of our portfolio and the momentum in our pipeline as we advance transformative treatments that address the world's toughest health challenges,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “With raised guidance and quarterly.

businesswire.com - 2026-07-15 06:20:00

What It Takes to Earn $8,000 a Month From Dividends Without Chasing Yield

Eight thousand dollars a month is the kind of retirement income target that looks simple until the yield math starts moving underneath it. It translates to $96,000 a year, but the portfolio needed to produce that income can vary by well over $1 million depending on whether the investor accepts a 3.5% yield, a 6%... What It Takes to Earn $8,000 a Month From Dividends Without Chasing Yield

247wallst.com - 2026-07-15 06:17:09

Nasdaq continues rally at open as PayPal climbs on bid, BlackRock earnings impress

10am: PayPal and BlackRock lead Wall St higher at open Wall Street has opened Wednesday trading on the front foot, with investors digesting more earnings....

proactiveinvestors.com - 2026-07-15 06:00:00

Morgan Stanley, Johnson & Johnson And 3 Stocks To Watch Heading Into Wednesday

With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

benzinga.com - 2026-07-15 02:29:24

This Healthcare Giant Still Checks Every Box for Long-Term Investors

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) has been one of 2026's quieter winners in large-cap healthcare, and our proprietary model sees room to run.

247wallst.com - 2026-07-14 12:30:20

Wall Street closes higher as cooling inflation lifts chip stocks, rate hopes

4:20pm: Rate hopes lift markets US stocks finished mostly higher on Tuesday after a softer-than-expected inflation report boosted hopes that the Federal...

proactiveinvestors.com - 2026-07-14 12:25:00

A $1.4 Million Portfolio That Delivers Reliable Income Through Bull and Bear Markets

A $1.4 million nest egg is far above the typical U.S. retirement account balance, but the check it writes each month depends entirely on how the assets are arranged. At a 3.5% yield, the portfolio produces $49,000 a year. At a 10% yield, it produces $140,000. The difference looks simple on a spreadsheet, but it... A $1.4 Million Portfolio That Delivers Reliable Income Through Bull and Bear Markets

247wallst.com - 2026-07-14 12:12:27

Johnson & Johnson Q2 Preview: Stock Near All-Time Highs, Market Expert Sees Rally to $282 – ‘Continue Their Winning Ways'

Health care giant Johnson & Johnson (NYSE:JNJ) reports second-quarter financial results on Wednesday before the market opens. Here are the earnings estimates, what experts are saying and key items to watch.

benzinga.com - 2026-07-14 11:55:20

Healthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD Surge

JNJ's 25% year-to-date surge and recent FDA approval fuel interest in healthcare ETFs with diversified sector exposure.

zacks.com - 2026-07-14 10:56:28

A Dividend Portfolio That Can Cover the Cost of Living in San Francisco

San Francisco makes passive income math unforgiving. SmartAsset's 2026 comfort-salary study estimates that a single adult needs about $134,950 in pretax income to live comfortably in the city, among the highest figures in the country. Turning that paycheck into dividend income is not just a yield exercise. The yield an investor reaches for changes both... A Dividend Portfolio That Can Cover the Cost of Living in San Francisco

247wallst.com - 2026-07-14 10:03:33

How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q2 Earnings

Johnson & Johnson (NYSE:JNJ) will release its second-quarter earnings report before the opening bell on Wednesday, July 15.

benzinga.com - 2026-07-14 08:40:20

CleanSpark shares surge after company secures $6.6B data center lease agreement

CleanSpark Inc (NASDAQ:CLSK) shares surged more than 12% after the company announced a 20-year lease agreement for its Sandersville, Georgia data center...

proactiveinvestors.com - 2026-07-14 07:53:00

Tower Semiconductor shares jump as company announces Japan expansion to boost silicon photonics capacity

Tower Semiconductor (NASDAQ:TSEM) shares rose 13% on Tuesday after the company announced a strategic expansion of its silicon photonics, silicon germanium...

proactiveinvestors.com - 2026-07-14 07:20:00

This Dividend King Has Raised Its Payout for More Than 60 Straight Years. But Is the Stock Still a Buy?

The dividend looks secure. The share price is the harder call.

fool.com - 2026-07-14 03:41:00

Is Johnson & Johnson Stock Poised for New Highs as Q2 Results Approach?

After hitting fresh all-time highs last week, investors are turning their attention to JNJ's Q2 report, which is scheduled for Wednesday, July 15, before the opening bell.

zacks.com - 2026-07-13 18:51:20

How Much of Your Social Security Will You Actually Keep After Taxes?

Social Security benefits come with inflation protection, but the tax formula attached to those benefits does not. For retirees with pensions, IRA withdrawals, taxable investment income, or municipal bond interest, a larger benefit can quietly mean a larger federal tax bill. The result is a tax rule from the 1980s that reaches more retirees every... How Much of Your Social Security Will You Actually Keep After Taxes?

247wallst.com - 2026-07-13 14:28:09

How To Build A $50,000 Dividend Portfolio In Today's Market

The Dividend Income Accelerator Portfolio emphasizes high-quality companies with sustainable dividends, strong balance sheets, and attractive valuations to optimize risk-adjusted returns. I prioritize a diversified mix of ETFs and individual stocks across sectors, balancing dividend income, growth, and capital appreciation while mitigating downside risk. Key metrics include a 3.75% weighted average dividend yield, low payout ratios, and low beta factors, supporting long-term portfolio resilience.

seekingalpha.com - 2026-07-13 13:45:49

Stock Indexes Split as Chip Stocks Fall, Oil Surges

Why are chip stocks collapsing while the Dow barely budges? Korean markets just had their worst day since the 2008 financial crisis, and the fallout is hitting semiconductors hard.

fool.com - 2026-07-13 12:23:17

JNJ Vs. KO: Which Dividend Stock Is The Better Buy?

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Coca-Cola (NYSE:KO) both delivered Q1 2026 beats and both are being crowded into by capital rotating out of tech.

247wallst.com - 2026-07-13 12:22:59

Is JNJ Stock a Buy, Sell or Hold Ahead of Q2 Earnings Release?

JNJ is set to report second-quarter results on July 15 as investors weigh strong growth drivers, new launches and patent headwinds shaping its long-term outlook.

zacks.com - 2026-07-13 11:45:20

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

zacks.com - 2026-07-13 09:56:19

The Real Case for Buying Johnson & Johnson (JNJ) Before July 15

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) is the easiest healthcare name to evaluate on the board heading into its July 15 earnings release, and the setup leaves little to debate.

247wallst.com - 2026-07-13 08:30:17

This Portfolio Lets You Earn More Than a Lawyer... Without Going to Law School

A legal career can eventually deliver a six-figure income, but the path is rarely passive. The median annual wage for lawyers was $151,160 in May 2024, and attorneys in higher-paid roles can clear $200,000 or more. The tradeoff is years of training, tuition, billable hours, and pressure that does not disappear when the workday ends.... This Portfolio Lets You Earn More Than a Lawyer... Without Going to Law School

247wallst.com - 2026-07-13 06:45:04

The Dividend Growth Roadmap That Turns $60,000 a Year Into More Than $125,000

The math on replacing $60,000 of annual income looks simple until you ask a different question. At a 3.5% yield, you need roughly $1.7 million. At 6%, you need about $1 million. At 12%, you need around $500,000. Three tiers, three price tags, and three very different risk profiles. The trap is treating that choice... The Dividend Growth Roadmap That Turns $60,000 a Year Into More Than $125,000

247wallst.com - 2026-07-13 05:00:37

3 Dividend Stocks Leading 2026's Rotation Into Value

As investors flee this year's high flyers, a few dependable payers are catching the money.

fool.com - 2026-07-12 20:38:00

Billionaire Ken Griffin Boosted His Stake in This Dividend King by 146%. Here's Why It's a Dream Stock for Risk-Averse Investors.

Griffin is at the helm of the world's most profitable hedge fund.

fool.com - 2026-07-12 17:10:00

Get JNJ Insider Trade Alerts

JNJ Price Target Summary

Last Month

$280.20

5 analysts

Last Quarter

$276.00

7 analysts

Last Year

$234.71

42 analysts

All Time

$204.02

88 analysts

JNJ Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-07-13 RBC Capital Maintain Outperform Outperform
2026-07-13 TD Cowen Maintain Buy Buy
2026-07-10 B of A Securities Maintain Neutral Neutral
2026-07-08 Morgan Stanley Maintain Overweight Overweight
2026-07-08 Citigroup Maintain Buy Buy
2026-06-26 Guggenheim Maintain Buy Buy
2026-05-13 Leerink Partners Upgrade Market Perform Outperform
2026-04-15 Stifel Maintain Hold Hold
2026-04-15 Barclays Maintain Equal Weight Equal Weight
2026-04-15 Wells Fargo Maintain Overweight Overweight
2026-04-10 Morgan Stanley Maintain Overweight Overweight
2026-03-30 RBC Capital Maintain Outperform Outperform
2026-03-19 Barclays Maintain Equal Weight Equal Weight
2026-03-17 HSBC Maintain Buy Buy
2026-03-11 Citigroup Maintain Buy Buy
2026-03-05 JP Morgan Maintain Neutral Neutral
2026-02-03 RBC Capital Maintain Outperform Outperform
2026-01-28 Morgan Stanley Upgrade Equal Weight Overweight
2026-01-27 Freedom Broker Maintain Hold Hold
2026-01-27 Freedom Capital Markets Maintain Hold Hold
2026-01-23 Guggenheim Maintain Buy Buy
2026-01-22 TD Cowen Maintain Buy Buy
2026-01-22 B of A Securities Maintain Neutral Neutral
2026-01-22 Morgan Stanley Maintain Equal Weight Equal Weight
2026-01-22 Stifel Maintain Hold Hold
2026-01-22 Scotiabank Maintain Sector Outperform Sector Outperform
2026-01-22 Citigroup Maintain Buy Buy
2026-01-22 Wells Fargo Maintain Overweight Overweight
2026-01-09 Bernstein Maintain Market Perform Market Perform
2025-12-30 Barclays Maintain Equal Weight Equal Weight
2025-12-19 Goldman Sachs Maintain Buy Buy
2025-12-15 B of A Securities Maintain Neutral Neutral
2025-12-12 Morgan Stanley Maintain Equal Weight Equal Weight
2025-12-11 RBC Capital Maintain Outperform Outperform
2025-12-11 Citigroup Maintain Buy Buy
2025-12-05 Guggenheim Maintain Buy Buy
2025-12-02 Barclays Maintain Equal Weight Equal Weight
2025-10-22 Freedom Broker Downgrade Buy Hold
2025-10-22 Freedom Capital Markets Downgrade Buy Hold
2025-10-15 B of A Securities Maintain Neutral Neutral
2025-10-15 Morgan Stanley Maintain Equal Weight Equal Weight
2025-10-15 Citigroup Maintain Buy Buy
2025-10-15 Raymond James Maintain Outperform Outperform
2025-10-15 Stifel Maintain Hold Hold
2025-10-14 UBS Maintain Buy Buy
2025-10-10 Morgan Stanley Maintain Equal Weight Equal Weight
2025-10-09 Goldman Sachs Maintain Buy Buy
2025-10-07 Citigroup Maintain Buy Buy
2025-10-06 Bernstein Maintain Market Perform Market Perform
2025-10-03 B of A Securities Maintain Neutral Neutral
2025-10-03 Wells Fargo Upgrade Equal Weight Overweight
2025-09-23 Guggenheim Upgrade Neutral Buy
2025-09-16 JP Morgan Maintain Neutral Neutral
2025-08-21 Citigroup Maintain Buy Buy
2025-07-17 UBS Maintain Buy Buy
2025-07-17 Morgan Stanley Maintain Equal Weight Equal Weight
2025-07-17 Guggenheim Maintain Neutral Neutral
2025-07-17 B of A Securities Maintain Neutral Neutral
2025-07-17 RBC Capital Maintain Outperform Outperform
2025-07-17 Barclays Maintain Equal Weight Equal Weight
2025-07-10 Morgan Stanley Maintain Equal Weight Equal Weight
2025-06-05 RBC Capital Maintain Outperform Outperform
2025-05-13 Leerink Partners Downgrade Outperform Market Perform
2025-04-17 Barclays Maintain Equal Weight Equal Weight
2025-04-16 Raymond James Maintain Outperform Outperform
2025-04-16 RBC Capital Maintain Outperform Outperform
2025-04-16 Morgan Stanley Maintain Equal Weight Equal Weight
2025-04-14 Raymond James Maintain Outperform Outperform
2025-04-10 B of A Securities Maintain Neutral Neutral
2025-04-09 Morgan Stanley Maintain Equal Weight Equal Weight
2025-04-09 Goldman Sachs Upgrade Neutral Buy
2025-04-03 RBC Capital Maintain Outperform Outperform
2025-04-02 RBC Capital Maintain Outperform Outperform
2025-04-02 Guggenheim Maintain Neutral Neutral
2025-03-12 Guggenheim Maintain Neutral Neutral
2025-03-10 Guggenheim Maintain Neutral Neutral
2025-03-05 B of A Securities Maintain Neutral Neutral
2025-02-19 RBC Capital Maintain Outperform Outperform
2025-02-03 Guggenheim Maintain Neutral Neutral
2025-01-28 Barclays Maintain Equal Weight Equal Weight
2025-01-23 Stifel Maintain Hold Hold
2025-01-23 Morgan Stanley Maintain Equal Weight Equal Weight
2025-01-23 RBC Capital Maintain Outperform Outperform
2025-01-23 Wells Fargo Maintain Equal Weight Equal Weight
2025-01-23 Raymond James Maintain Outperform Outperform
2025-01-23 B of A Securities Maintain Neutral Neutral
2025-01-23 Leerink Partners Maintain Outperform Outperform
2025-01-17 B of A Securities Maintain Neutral Neutral
2024-12-11 Citigroup Maintain Buy Buy
2024-11-06 Guggenheim Maintain Neutral Neutral
2024-10-16 RBC Capital Maintain Outperform Outperform
2024-10-16 Wells Fargo Maintain Equal Weight Equal Weight
2024-10-16 Morgan Stanley Maintain Equal Weight Equal Weight
2024-10-16 Cantor Fitzgerald Maintain Overweight Overweight
2024-10-16 Citigroup Maintain Buy Buy
2024-10-10 Cantor Fitzgerald Maintain Overweight Overweight
2024-10-08 RBC Capital Maintain Outperform Outperform
2024-09-30 Cantor Fitzgerald Maintain Overweight Overweight
2024-09-23 Cantor Fitzgerald Maintain Overweight Overweight
2024-09-20 RBC Capital Maintain Outperform Outperform
2024-09-19 Cantor Fitzgerald Maintain Overweight Overweight
2024-09-16 Cantor Fitzgerald Maintain Overweight Overweight
2024-09-09 Cantor Fitzgerald Maintain Overweight Overweight
2024-09-03 Cantor Fitzgerald Maintain Overweight Overweight
2024-08-05 Cantor Fitzgerald Maintain Overweight Overweight
2024-07-30 Cantor Fitzgerald Maintain Overweight Overweight
2024-07-30 RBC Capital Maintain Outperform Outperform
2024-07-23 Daiwa Capital Downgrade Outperform Neutral
2024-07-19 Goldman Sachs Maintain Neutral Neutral
2024-07-18 RBC Capital Maintain Outperform Outperform
2024-07-18 Morgan Stanley Maintain Equal Weight Equal Weight
2024-07-18 TD Cowen Maintain Buy Buy
2024-07-01 Cantor Fitzgerald Maintain Overweight Overweight
2024-06-25 Cantor Fitzgerald Maintain Overweight Overweight
2024-06-20 Cantor Fitzgerald Maintain Overweight Overweight
2024-06-17 RBC Capital Maintain Outperform Outperform
2024-06-04 RBC Capital Maintain Outperform Outperform
2024-05-22 RBC Capital Maintain Outperform Outperform
2024-05-16 RBC Capital Maintain Outperform Outperform
2024-05-06 Cantor Fitzgerald Maintain Overweight Overweight
2024-04-18 HSBC Upgrade Hold Buy
2024-04-17 B of A Securities Maintain Neutral Neutral
2024-04-17 Morgan Stanley Maintain Equal Weight Equal Weight
2024-04-17 RBC Capital Maintain Outperform Outperform
2024-04-17 Cantor Fitzgerald Maintain Overweight Overweight
2024-04-15 Cantor Fitzgerald Maintain Overweight Overweight
2024-03-13 Cantor Fitzgerald Maintain Overweight Overweight
2024-02-28 RBC Capital Maintain Outperform Outperform
2024-02-20 Cantor Fitzgerald Maintain Overweight Overweight
2024-02-06 Cantor Fitzgerald Maintain Overweight Overweight
2024-01-24 RBC Capital Maintain Outperform Outperform
2024-01-24 Cantor Fitzgerald Maintain Overweight Overweight
2024-01-24 Morgan Stanley Maintain Equal Weight Equal Weight
2024-01-23 Cantor Fitzgerald Maintain Overweight Overweight
2024-01-09 Cantor Fitzgerald Maintain Overweight Overweight
2024-01-03 Raymond James Maintain Outperform Outperform
2023-12-13 Wells Fargo Downgrade Overweight Equal Weight
2023-12-06 RBC Capital Maintain Outperform Outperform
2023-12-01 RBC Capital Maintain Outperform Outperform
2023-12-01 UBS Upgrade Neutral Buy
2023-11-20 Cantor Fitzgerald Maintain Overweight Overweight
2023-11-17 Cantor Fitzgerald Maintain Overweight Overweight
2023-10-23 Cantor Fitzgerald Maintain Overweight Overweight
2023-10-18 Raymond James Maintain Outperform Outperform
2023-10-18 Morgan Stanley Maintain Equal Weight Equal Weight
2023-10-18 Cantor Fitzgerald Maintain Overweight Overweight
2023-10-12 Barclays Maintain Equal Weight Equal Weight
2023-10-11 Cantor Fitzgerald Maintain Overweight Overweight
2023-10-11 Morgan Stanley Maintain Equal Weight Equal Weight
2023-10-09 Cantor Fitzgerald Maintain Overweight Overweight
2023-10-02 Cantor Fitzgerald Maintain Overweight Overweight
2023-09-18 Cantor Fitzgerald Maintain Overweight Overweight
2023-09-08 Barclays Maintain Equal Weight Equal Weight
2023-09-05 Cantor Fitzgerald Maintain Overweight Overweight
2023-09-05 Raymond James Maintain Outperform Outperform
2023-08-31 Cantor Fitzgerald Maintain Overweight Overweight
2023-08-31 Morgan Stanley Maintain Equal Weight Equal Weight
2023-08-31 Wells Fargo Maintain Overweight Overweight
2023-08-30 Cantor Fitzgerald Maintain Overweight Overweight
2023-08-22 Cantor Fitzgerald Maintain Overweight Overweight
2023-08-04 Atlantic Equities Maintain Neutral Neutral
2023-07-31 Cantor Fitzgerald Maintain Overweight Overweight
2023-07-25 Barclays Maintain Equal Weight Equal Weight
2023-07-24 Raymond James Maintain Outperform Outperform
2023-07-21 Morgan Stanley Maintain Equal Weight Equal Weight
2023-07-21 Credit Suisse Maintain Neutral Neutral
2023-07-21 JP Morgan Maintain Neutral Neutral
2023-07-13 Cantor Fitzgerald Maintain Overweight Overweight
2023-07-11 Morgan Stanley Maintain Equal Weight Equal Weight
2023-06-07 Mizuho Maintain Buy Buy
2023-04-19 Morgan Stanley Maintain Equal Weight Equal Weight
2023-04-19 Atlantic Equities Maintain Neutral Neutral
2023-04-19 Raymond James Maintain Outperform Outperform
2023-04-10 Morgan Stanley Maintain Equal Weight Equal Weight
2023-03-29 UBS Maintain Neutral Neutral
2023-03-01 Guggenheim Maintain Neutral Neutral
2023-02-01 Cantor Fitzgerald Maintain Overweight Overweight
2023-01-25 Morgan Stanley Maintain Equal Weight Equal Weight
2023-01-25 Atlantic Equities Maintain Neutral Neutral
2023-01-20 SVB Leerink Maintain Outperform Outperform
2022-12-12 Citigroup Maintain Buy Buy
2022-12-06 Morgan Stanley Maintain Equal Weight Equal Weight
2022-12-01 Morgan Stanley Maintain Equal Weight Equal Weight
2022-11-18 Credit Suisse Maintain Neutral Neutral
2022-10-19 Raymond James Maintain Outperform Outperform
2022-10-19 Atlantic Equities Maintain Neutral Neutral
2022-10-19 Morgan Stanley Maintain Equal Weight Equal Weight
2022-10-18 Barclays Maintain Equal Weight Equal Weight
2022-10-12 Morgan Stanley Maintain Equal Weight Equal Weight
2022-09-12 Morgan Stanley Maintain Equal Weight Equal Weight
2022-07-21 UBS Maintain Neutral Neutral
2022-07-20 Raymond James Maintain Outperform Outperform
2022-07-20 Citigroup Maintain Buy Buy
2022-07-20 SVB Leerink Maintain Outperform Outperform
2022-07-20 Atlantic Equities Maintain Neutral Neutral
2022-07-13 Wells Fargo Maintain Overweight Overweight
2022-07-08 Morgan Stanley Maintain Equal Weight Equal Weight
2022-05-17 Citigroup Maintain Buy Buy
2022-04-20 Raymond James Maintain Outperform Outperform
2022-04-20 Citigroup Maintain Buy Buy
2022-04-20 Credit Suisse Maintain Outperform Outperform
2022-04-14 Raymond James Maintain Outperform Outperform
2022-04-12 Goldman Sachs Maintain Neutral Neutral
2022-04-06 Morgan Stanley Maintain Equal Weight Equal Weight
2022-03-16 Bernstein Downgrade Outperform Market Perform
2022-01-26 Raymond James Maintain Outperform Outperform
2022-01-24 Morgan Stanley Maintain Equal Weight Equal Weight
2021-12-17 Goldman Sachs Maintain Neutral Neutral
2021-10-20 Raymond James Maintain Outperform Outperform
2021-09-07 Morgan Stanley Downgrade Overweight Equal Weight
2021-01-27 Morgan Stanley Maintain Overweight Overweight
2021-01-27 Credit Suisse Maintain Outperform Outperform
2021-01-27 Raymond James Maintain Outperform Outperform
2021-01-27 Wells Fargo Maintain Overweight Overweight
2021-01-27 SVB Leerink Maintain Outperform Outperform
2021-01-26 Cantor Fitzgerald Maintain Overweight Overweight
2020-12-15 Morgan Stanley Maintain Overweight Overweight
2020-10-14 Cantor Fitzgerald Maintain Overweight Overweight
2020-10-14 Credit Suisse Maintain Outperform Outperform
2020-07-20 Independent Research Upgrade Hold Buy
2020-07-17 Citigroup Maintain Buy Buy
2020-07-17 Raymond James Maintain Outperform Outperform
2020-04-29 Morgan Stanley Maintain Overweight Overweight
2020-04-29 Barclays Maintain Overweight Overweight
2020-04-28 UBS Downgrade Buy Neutral
2020-04-22 B of A Securities Upgrade Neutral Buy
2020-04-15 Stifel Maintain Hold Hold
2020-04-15 Wells Fargo Maintain Overweight Overweight
2020-04-15 Raymond James Maintain Outperform Outperform
2020-04-15 Citigroup Maintain Buy Buy
2020-04-15 Credit Suisse Maintain Outperform Outperform
2020-04-08 SVB Leerink Maintain Outperform Outperform
2020-04-02 Wells Fargo Maintain Overweight Overweight
2020-04-01 Stifel Maintain Hold Hold
2020-03-27 Morgan Stanley Maintain Overweight Overweight
2020-03-27 Citigroup Maintain Buy Buy
2020-03-27 Argus Research Maintain Buy Buy
2020-03-06 Credit Suisse Maintain Outperform Outperform
2020-03-05 Citigroup Maintain Buy Buy
2020-01-27 Credit Suisse Maintain Outperform Outperform
2020-01-23 Raymond James Maintain Outperform Outperform
2020-01-09 Wells Fargo Maintain Overweight Overweight
2019-12-19 Barclays Upgrade Equal Weight Overweight
2019-12-17 Morgan Stanley Upgrade Equal Weight Overweight
2019-11-20 Cantor Fitzgerald Maintain Overweight Overweight
2019-10-24 Credit Suisse Maintain Outperform Outperform
2019-10-16 Atlantic Equities Upgrade Underweight Neutral
2019-10-16 Wells Fargo Maintain Outperform Outperform
2019-10-16 Credit Suisse Maintain Outperform Outperform
2019-10-14 Raymond James Maintain Outperform Outperform
2019-10-11 Bernstein Upgrade Market Perform Outperform
2019-08-27 Morgan Stanley Maintain Equal Weight Equal Weight
2019-07-17 Raymond James Maintain Outperform Outperform
2019-07-12 Credit Suisse Maintain Outperform Outperform
2019-05-16 Credit Suisse Maintain Outperform Outperform
2019-04-17 BMO Capital Maintain Outperform Outperform
2019-04-17 Raymond James Maintain Outperform Outperform
2019-04-17 Morgan Stanley Maintain Equal Weight Equal Weight
2019-04-17 Credit Suisse Maintain Outperform Outperform
2019-02-25 Citigroup Maintain Neutral Neutral
2019-01-14 Wells Fargo Maintain Outperform Outperform
2019-01-02 Citigroup Maintain Neutral Neutral
2019-01-02 Morgan Stanley Maintain Equal Weight Equal Weight
2018-10-22 Citigroup Maintain Neutral Neutral
2018-10-17 Credit Suisse Maintain Outperform Outperform
2018-10-17 Raymond James Maintain Outperform Outperform
2018-10-11 Morgan Stanley Maintain Equal Weight Equal Weight
2018-07-12 Goldman Sachs Upgrade Sell Neutral
2018-06-27 Bernstein Maintain Market Perform Perform
2018-05-05 Argus Maintain Buy Buy
2018-05-05 Argus Upgrade Hold Buy
2018-04-20 Credit Suisse Maintain Outperform Outperform
2018-04-18 Stifel Maintain Hold Hold
2018-04-18 Stifel Nicolaus Maintain Hold Hold
2018-04-10 Morgan Stanley Maintain Equal Weight Equal Weight
2018-02-28 Citigroup Maintain Neutral Neutral
2018-02-27 Citigroup Maintain Neutral Neutral
2018-01-24 Stifel Maintain Hold Hold
2018-01-24 Stifel Nicolaus Maintain Hold Hold
2018-01-02 JP Morgan Downgrade Overweight Neutral
2017-10-23 Citigroup Maintain Buy Buy
2017-10-19 Credit Suisse Maintain Outperform Outperform
2017-10-18 Argus Research Maintain Buy Buy
2017-10-18 Barclays Maintain Equal Weight Equal Weight
2017-10-18 Argus Maintain Buy Buy
2017-10-18 Morgan Stanley Maintain Equal Weight Equal Weight
2017-10-18 BMO Capital Maintain Outperform Outperform
2017-10-11 Jefferies Upgrade Hold Buy
2017-10-09 Wells Fargo Upgrade Market Perform Outperform
2017-09-20 Goldman Sachs Downgrade Neutral Sell
2017-07-21 Atlantic Equities Downgrade Neutral Underweight
2017-07-21 BTIG Research Downgrade Neutral Sell
2017-07-21 BTIG Downgrade Neutral Sell
2017-05-15 JP Morgan Upgrade Neutral Overweight
2017-01-26 Wells Fargo Downgrade Outperform Market Perform
2016-11-29 Barclays Downgrade Overweight Equal Weight
2016-09-13 Jefferies Maintain Hold Hold
2016-08-04 Jefferies Maintain Hold Hold
2016-07-20 Argus Upgrade Hold Buy
2016-07-20 Argus Research Upgrade Hold Buy
2016-07-14 Jefferies Maintain Hold Hold
2016-06-14 Jefferies Maintain Hold Hold
2016-05-20 Standpoint Research Maintain Sell Sell
2016-05-12 BTIG Research Downgrade Buy Neutral
2016-05-12 BTIG Downgrade Buy Neutral
2016-05-01 Credit Suisse Maintain Neutral Neutral
2016-04-20 Argus Research Maintain Buy Buy
2016-04-20 Barclays Maintain Overweight Overweight
2016-04-20 Goldman Sachs Maintain Neutral Neutral
2016-04-20 Argus Maintain Buy Buy
2016-04-06 Societe Generale Maintain Hold Hold
2016-03-15 Jefferies Maintain Hold Hold
2016-03-14 Goldman Sachs Upgrade Sell Neutral
2016-02-04 Deutsche Bank Maintain Buy Buy
2016-01-14 Jefferies Maintain Hold Hold
2015-12-18 Atlantic Equities Maintain Neutral Neutral
2015-12-01 Barclays Upgrade Equal Weight Overweight
2015-09-29 Deutsche Bank Upgrade Hold Buy
2015-09-22 UBS Maintain Buy Buy
2015-08-07 Jefferies Maintain Hold Hold
2015-05-21 Jefferies Maintain Hold Hold
2015-05-20 Deutsche Bank Maintain Hold Hold
2015-04-20 Deutsche Bank Maintain Hold Hold
2015-04-06 JP Morgan Maintain Neutral Neutral
2015-03-10 Jefferies Maintain Hold Hold
2015-02-20 Jefferies Maintain Hold Hold
2015-01-22 Barclays Maintain Equal Weight Equal Weight
2015-01-21 Jefferies Maintain Hold Hold
2015-01-16 Barclays Maintain Equal Weight Equal Weight
2015-01-15 Jefferies Maintain Hold Hold
2015-01-15 Goldman Sachs Downgrade Neutral Sell
2014-12-16 JP Morgan Maintain Neutral Neutral
2014-12-04 Jefferies Maintain Hold Hold
2014-10-02 Guggenheim Maintain Neutral Neutral
2014-10-01 Bernstein Maintain Market Perform Perform
2014-08-11 Jefferies Maintain Hold Hold
2014-07-16 Citigroup Maintain Buy Buy
2014-07-16 Deutsche Bank Maintain Hold Hold
2014-07-14 Jefferies Maintain Hold Hold
2014-07-02 Barclays Maintain Equal Weight Equal Weight
2014-06-30 JP Morgan Maintain Neutral Neutral
2014-05-05 Citigroup Maintain Buy Buy
2014-04-16 JP Morgan Maintain Neutral Neutral
2014-04-16 Citigroup Maintain Buy Buy
2014-04-16 Credit Suisse Maintain Underperform Underperform
2014-04-16 B of A Securities Maintain Neutral Neutral
2014-04-16 Raymond James Maintain Outperform Outperform
2014-04-16 Bank of America Maintain Neutral Neutral
2014-04-14 Jefferies Downgrade Buy Hold
2014-01-10 Barclays Downgrade Overweight Equal Weight
2014-01-09 Jefferies Upgrade Hold Buy
2014-01-07 RBC Capital Upgrade Sector Perform Outperform
2013-10-11 Goldman Sachs Upgrade Sell Neutral
2013-07-17 Deutsche Bank Downgrade Buy Hold
2013-07-12 Jefferies Maintain Hold Hold
2013-06-07 Jefferies Maintain Hold Hold
2013-05-28 Jefferies Maintain Hold Hold
2013-04-19 Jefferies Maintain Hold Hold
2013-04-12 Deutsche Bank Maintain Buy Buy
2013-04-10 Jefferies Maintain Hold Hold
2013-04-08 JP Morgan Downgrade Overweight Neutral
2013-03-26 UBS Maintain Buy Buy
2013-02-07 Credit Suisse Downgrade Neutral Underperform
2013-01-16 Jefferies Maintain Hold Hold
2013-01-11 UBS Maintain Buy Buy
2013-01-04 Deutsche Bank Upgrade Hold Buy
2012-12-10 Davenport Maintain Neutral Hold
2012-11-20 Stifel Nicolaus Maintain Hold Hold
2012-11-12 Jefferies Downgrade Buy Hold
2012-10-17 Deutsche Bank Maintain Hold Hold
2012-10-17 Barclays Maintain Overweight Overweight
2012-10-12 Jefferies Maintain Buy Buy
2012-08-01 UBS Maintain Buy Buy
2012-07-18 Jefferies Maintain Buy Buy
2012-07-18 Piper Sandler Maintain Neutral Neutral
2012-07-18 Deutsche Bank Maintain Hold Hold
2012-07-18 PiperJaffray Maintain Neutral Neutral
2012-07-13 Jefferies Maintain Buy Buy
2012-04-18 Citigroup Maintain Buy Buy
2012-04-18 UBS Maintain Buy Buy
2012-04-18 Goldman Sachs Maintain Neutral Neutral
2012-04-16 Citigroup Maintain Buy Buy